Item 8.01 Other Events
On April 26, 2023, Intelligent Medicine Acquisition Corp. (the "Company") issued
a press release announcing that, because it does not believe it can consummate
an initial combination within the time period required by its Amended and
Restated Certificate of Incorporation (the "Charter"), it intends to dissolve
and liquidate in accordance with the provisions of the Charter and will redeem
all of its remaining shares of Class A common stock that were included in the
units issued in its initial public offering. In addition, the Company no longer
intends to proceed with respect to the hearing before the Nasdaq Hearings Panel
to appeal Nasdaq's determination that the Company no longer meets certain
listing standards. As a result, Nasdaq will suspend trading of the Company's
shares at the open of business on April 27, 2023, and the Company expects that
Nasdaq will proceed with delisting the Company's securities. A copy of the press
release is attached hereto as Exhibit 99.1 and is incorporated herein by
reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:
Exhibit Description
99.1 Press Release dated April 26, 2023
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document).
© Edgar Online, source Glimpses